Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


15.07.2019

2 Acta Neurol Scand
1 BMC Neurol
1 Brain
3 J Immunol
2 Lancet Neurol
1 Nervenarzt
2 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. TOLF A, Fagius J, Carlson K, Akerfeldt T, et al
    Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
    Acta Neurol Scand. 2019 Jul 12. doi: 10.1111/ane.13147.
    PubMed     Text format     Abstract available

  2. PAKDEL M, Hedstrom A, Bidkhori M, Hadei M, et al
    Do socio-economic factors affect prevalence of multiple sclerosis in Iran?
    Acta Neurol Scand. 2019 Jul 10. doi: 10.1111/ane.13148.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. ZECCA C, Disanto G, Sacco R, Riccitelli GC, et al
    Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients.
    BMC Neurol. 2019;19:159.
    PubMed     Text format     Abstract available


    Brain

  4. FITZGERALD KC, Kim K, Smith MD, Aston SA, et al
    Early complement genes are associated with visual system degeneration in multiple sclerosis.
    Brain. 2019 Jul 9. pii: 5530228. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Immunol

  5. GALICIA G, Lee DSW, Ramaglia V, Ward LA, et al
    Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda(-/-) and Ung(-/-) Mice.
    J Immunol. 2018 Jul 6. pii: jimmunol.1700729. doi: 10.4049/jimmunol.1700729.
    PubMed     Text format     Abstract available

  6. WAN X, Pei W, Shahzad KA, Zhang L, et al
    A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4(+) and CD8(+) T Cells.
    J Immunol. 2018 Jul 9. pii: jimmunol.1800108. doi: 10.4049/jimmunol.1800108.
    PubMed     Text format     Abstract available

  7. LINDAHL H, Guerreiro-Cacais AO, Bedri SK, Linnerbauer M, et al
    IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.
    J Immunol. 2019 Jul 10. pii: jimmunol.1900400. doi: 10.4049/jimmunol.1900400.
    PubMed     Text format     Abstract available


    Lancet Neurol

  8. ADLER AI, Knight H
    Ocrelizumab for primary progressive multiple sclerosis.
    Lancet Neurol. 2019 Jul 3. pii: S1474-4422(19)30245.
    PubMed     Text format    

  9. CADAVID D, Mellion M, Hupperts R, Edwards KR, et al
    Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2019 Jul 5. pii: S1474-4422(19)30137.
    PubMed     Text format     Abstract available


    Nervenarzt

  10. BITTNER S, Engel S, Lange C, Weber MS, et al
    [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].
    Nervenarzt. 2019 Jul 11. pii: 10.1007/s00115-019-0760.
    PubMed     Text format     Abstract available


    Neurology

  11. LAPLAUD DA, Casey R, Barbin L, Debouverie M, et al
    Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
    Neurology. 2019 Jul 12. pii: WNL.0000000000007938.
    PubMed     Text format     Abstract available

  12. HERSH CM, Marrie RA
    Harnessing real-world data to inform treatment decisions in multiple sclerosis.
    Neurology. 2019 Jul 12. pii: WNL.0000000000007934.
    PubMed     Text format    


    PLoS One

  13. AZAMI M, YektaKooshali MH, Shohani M, Khorshidi A, et al
    Correction: Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0219466.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  14. LISAK RP
    Human retrovirus pHEV-W envelope protein and the pathogenesis of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2019 Jul 9. pii: 1909786116.
    PubMed     Text format    


    Rev Neurol

  15. DIEGUEZ-VARELA C, Lion-Vazquez S, Fraga-Bau A, Rodriguez-Acevedo B, et al
    [Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial].
    Rev Neurol. 2019;69:45-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: